search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size
  • Access and Reimbursement for Infectious Disease Services

    Access and Payments

    Fair and adequate reimbursement for infectious diseases physicians is a key IDSA policy priority. The Society also advocates for access to appropriate treatments for patients with serious infections and for medical liability reform. IDSA’s positions on specific reimbursement and access issues that impact the practice of infectious diseases and Advocacy Alerts to key policy priorities are provided below. 

    Home Infusion Therapy

    IDSA's Efforts in Access and Reimbursement for ID Services

    1/2/2018

    IDSA Comments on the 2018 Medicare Final Rule for the Quality Payment Program

    The Infectious Diseases Society of America (IDSA) appreciates the opportunity to provide comments on the 2018 final rule of the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Programs, collectively known as the Quality Payment Program (QPP).
    3/13/2018

    Physician Group Letter to HHS on Drug Pricing Proposals

    Physician Group Letter to HHS on Drug Pricing Proposals
    4/16/2018

    IDSA Urges CMS to Reduce 2018 MIPS Quality Reporting Period

    In coalition with other medical specialty societies, IDSA asks the Centers for Medicare & Medicaid Services (CMS) to reduce the 2018 Merit-based Incentive Payment System (MIPS) quality measure reporting period from a calendar year to a minimum of 90 consecutive days due to the lack of timely and direct notification by CMS on the MIPS eligibility status of physicians as well as delays in updating the Quality Payment Program (QPP) website with 2018 QPP reporting information.
    9/11/2017

    IDSA Comments on the CY2018 Medicare Physician Fee Schedule Proposed Rule

    IDSA provides comments on the Medicare Physician Fee Schedule (MPFS) proposed rule for calendar year 2018.
    8/21/2017

    IDSA Comments on the 2018 Medicare Proposed Rule for the Quality Payment Program

    IDSA provides comments on the 2018 Medicare Proposed Rule for the Merit-based Incentive Payment System (MIPS) and the Alternative Payment Model (APM) Incentive Programs, collectively known as the Quality Payment Program (QPP).
    2/27/2017

    AMA Sign-on Letter to CMS & ONC

    IDSA signs on to AMA letter addressed to CMS and ONC calling for a delay in implementing 2015 Edition certified electronic health record technology (CEHRT).
    4/17/2017

    Bicillin L-A and Penicillin G Procaine Shortage Update (PDF)

    Update from the CDC Division of STD Prevention regarding the ongoing shortage of Penicillin G benzathine (Bicillin L-A) and Penicillin G procaine in the U.S.
    12/16/2016

    IDSA Comments on the Medicare Final Rule for the Quality Payment Program

    IDSA provides comments on the Medicare Final Rule for the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Programs, collectively known as the Quality Payment Program (QPP). Specifically, IDSA provides further specifics on improvement activities (IAs), virtual groups, hospital-based physicians, and quality and cost measurement int he Medicare QPP.
    10/12/2016

    IDSA Jointly Provides Comments to CMS on the Sepsis National Hospital Inpatient Quality Measure

    In collaboration with the American College of Emergency Physicians, the Society of Critical Care Medicine, and the Society of Hospital Medicine, IDSA jointly submitted a letter to the Center for Medicare and Medicaid Services (CMS) expressing our concerns with the antibiotics listed for the Sepsis National Hospital Inpatient Quality Measure (SEP-1) and provided recommendations towards addressing the issue. 

    9/6/2016

    IDSA Jointly Comments on the CY2017 Medicare Physician Fee Schedule Proposed Rule

    As a member of the Cognitive Care Alliance, IDSA jointly comments on the CY2017 Physician Fee Schedule Propose Rule. Specifically, comments are provided on the collection of data on resources used in furnishing global services as well as improving payment accuracy for primary care, care management, and patient centered services.
    9/6/2016

    IDSA Comments on the CY2017 Medicare Physician Fee Schedule Proposed Rule

    IDSA provides comments on the Medicare Physician Fee Schedule (MPFS) Proposed Rule for calendar year 2017 regarding medicare telehealth services, non-face-to-face prolonged evaluation and management (E/M) services, improving payment accuracy for primary care, care management, and patient centered services, valuation of the global surgery codes, and proposed expansion of the diabetes prevention program (DPP) model.
    12/29/2015

    IDSA Comments on the CY2016 Physician Fee Schedule Final Rule

    IDSA provides comments on the Medicare Program Revisions to Payment Policies under the Physician Fee Schedule Final Rule for CY 2016 regarding the finalized changes for the Physician Quality Reporting System (PQRS) as well as the changes in the measure specifications that are concerning to IDSA. Additionally, IDSA also comments on improving payment accuracy for primary care and care management services and provisions related to the Merit-based Incentive Payment System (MIPS) and Alternative Payment Models (APMs) specified in Medicare Access and CHIP Reauthorization Act (MACRA).
    12/30/2015

    IDSA Responds to The Joint Commission's Proposed Standards for Antimicrobial Stewardship for Various Types of Healthcare Facilities

    IDSA responds to The Joint Commission's Proposed Standards for Antimicrobial Stewardship for various types of healthcare facilities that include Ambulatory Health Care Centers, Critical Access Hospitals, Hospitals, Nursing Homes, and Office-based Surgical Centers. Please review The Joint Commission’s Proposed Standards for Antimicrobial Stewardship to provide context to our comments.
    11/17/2015

    IDSA Responds to Request for Information Regarding Alternative Payment Models and Merit-Based Incentive Programs (PDF)

    IDSA responds to the Center for Medicare and Medicaid's (CMS) request for information regarding implementation of alternative payment models (APMs) and merit-based incentive payment system (MIPS) called for in the Medicare Access and CHIP Reauthorization Act (MACRA). IDSA expresses the challenges infectious diseases specialists face within the current regulatory quality environment as well as recommendations on how to best implement the new MACRA regulations, being cognizant of the nuances of the ID specialty.
    11/2/2015

    Medical Groups Call for Changes to the Meaningful Use Program (PDF)

    IDSA joined the AMA and over 100 other national and state societies in a letter asking leaders in Congress to make changes to the meaningful use program prior to implementation of its next phase, Stage 3.

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site